Integrative Multi-OMICs Identifies Therapeutic Response Biomarkers and Confirms Fidelity of Clinically Annotated, Serially Passaged Patient-Derived Xenografts Established from Primary and Metastatic Pediatric and AYA Solid Tumors
Pankita H. Pandya(Indiana University School of Medicine), Karen E. Pollok(Indiana University Health), Rada Malko(Indiana University School of Medicine), Ryli E. Justice(Indiana University School of Medicine), Nur P. Damayanti(University of Indianapolis), M. Reza Saadatzadeh(Indiana University School of Medicine), Erika A. Dobrota(Indiana University School of Medicine), Jamie L. Renbarger(Indiana University School of Medicine), Emanuel F. Petricoin(Center for Biologics Evaluation and Research), Khadijeh Bijangi‐Vishehsaraei(Indiana University School of Medicine), Julia Wulfkuhle(University of California, San Francisco), Eric A. Albright(Indiana University School of Medicine), L. Daniel Wurtz(Indiana University School of Medicine), Farinaz Barghi(Indiana University School of Medicine), Barbara J. Bailey(Indiana University School of Medicine), Kathy Coy(Indiana University Health), Rosa I. Gallagher(George Mason University), George E. Sandusky(Indiana University – Purdue University Indianapolis), Melissa A. Trowbridge(Indiana University Health), Niknam Riyahi(Indiana University School of Medicine), Kun Huang(Indiana University School of Medicine), Asha Jacob Jannu(Indiana University School of Medicine), Anthony L. Sinn(Indiana University Health), Christopher D. Collier(Indiana University School of Medicine), Jie Zhang(Indiana University School of Medicine), Mark S. Marshall(Eli Lilly (United States)), Michael J. Ferguson(Indiana University School of Medicine), Harlan E. Shannon(Indiana University School of Medicine), Courtney Young(Indiana University School of Medicine)
Cited by 14
Related Papers
Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trial
|The Lancet Oncology|2020|541
Increased Protein Kinase C Activity and Expression of Ca <sup>2+</sup> -Sensitive Isoforms in the Failing Human Heart
|Circulation|1999|457
Redefining breast cancer subtypes to guide treatment prioritization and maximize response: Predictive biomarkers across 10 cancer therapies
|Cancer Cell|2022|335